Key result
Miniaturized extracorporeal circulation (MECC) is an alternative strategy to conventional cardiopulmonary bypass designed to reduce adverse systemic effects during heart surgery.
Why the study?
Does miniaturized extracorporeal circulation (MECC) reduce morbidity in patients undergoing heart surgery compared to standard cardiopulmonary bypass?
Does miniaturized extracorporeal circulation (MECC) reduce morbidity in patients undergoing heart surgery compared to standard cardiopulmonary bypass?
Answers are grounded in this paper and cite their sources.
Miniaturized extracorporeal circulation (MECC) is discussed as an alternative strategy to reduce adverse systemic effects associated with standard cardiopulmonary bypass.
The advent of cardiopulmonary bypass (CPB) in the 1950s was a landmark advancement in clinical medicine, enabling the development of modern heart surgery.1 However, CPB is not without its consequences. Adverse systemic effects such as coagulopathy and inflammation precipitated by the contact of blood with air and plastic surfaces have been reported.2 Minimally invasive, or miniaturized, extracorporeal circulation (MECC) is an alternative strategy designed to reduce adverse effects by using a closed circuit, biologically inert surfaces, reduced priming volumes, and a centrifugal pump.
No takes yet. Share an insight, caveat, or question.
Prabhu et al. (2021) conducted an editorial in Heart surgery. Minimally invasive, or miniaturized, extracorporeal circulation (MECC) vs. Conventional cardiopulmonary bypass (CPB) was evaluated. Miniaturized extracorporeal circulation (MECC) is an alternative strategy to conventional cardiopulmonary bypass designed to reduce adverse systemic effects during heart surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: